“Two studies
published July 27 in JAMA Cardiology looked at how COVID-19 may impact the
heart”
LOS ANGELES – “In a study published
in September, researchers from Ohio State University found that out of more
than two dozen athletes from the university who tested positive for COVID-19,
30% had cellular heart damage and 15% showed signs of heart inflammation caused
by a condition known as myocarditis.
“After
mapping the hearts of 26 Ohio State University athletes using a process known
as cardiac magnetic resonance (CMR), researchers found that not only 15% of
students exhibited the rare heart condition but 30% showed cellular
damage. ‘Cardiac magnetic resonance imaging has the potential to identify
a high-risk cohort for adverse outcomes and may, importantly, risk-stratify
athletes for safe participation,’ study authors wrote. ‘Recent studies have
raised concerns of myocardial inflammation after recovery from coronavirus
disease 2019 (COVID-19), even in asymptomatic or mildly symptomatic patients.’
“According to researchers, ‘myocarditis is a significant cause of sudden cardiac death in competitive athletes.’ According to the Mayo Clinic, myocarditis is typically caused by a viral infection with symptoms ranging from chest pain, fatigue, shortness of breath, to a negative impact on heart rate and rhythm as seen in conditions such as arrhythmias.
“The U.S. Centers for Disease Control and Prevention tweeted on Sept. 17, ‘Heart conditions like myocarditis are associated with some cases of #COVID19. Severe cardiac damage is rare but has occurred, even in young, healthy people.’ Medical experts have previously warned the public of links between the novel coronavirus and heart damage, especially in young people.
“In a news release published on Dec. 2, the group of doctors said the infant recovered with normal heart function and was eventually discharged with no heart failure medications. ‘The presentation and clinical course of this patient mirrors four case reports of acute myocardial injury reported in adult patients with COVID-19,’ said Sharma.
“The researchers brought up the particularly alarming possibility that if COVID-19 can infect the heart cells in a laboratory setting, it could possibly infect those specific organs, prompting the need for a ‘cardiac-specific antiviral drug screen program’” (Fox6now.com).
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.